Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Artificial Intelligence (AI) Based, Machine Learning (ML) Predicting the Individual Absolute Risk of Acute Graft Versus Host Disease (aGvHD) in a Retrospective International Cohort

Madlen Reschke, Jonathan P. Gross, Olaf Penack, Gülüstan Sürücü, Corinne Summers, Jonas Seiler, Daniel Weschke, David Higgins, Lena Oevermann

Blood (2023) 142 (Supplement 1): 2196.

https://doi.org/10.1182/blood-2023-181535

Published: 2023

Journal Articles

Establishing Standard of Care in Predicting Serious Complications for Patients Planned to Undergo Allogenic Hematopeotic Stem Cell Transplantation

Madlen Reschke, Jonathan P. Gross, Janina Hegner, Jonas Seiler, Gülüstan Sürücü, Olaf Penack, Daniel Weschke, David Higgins, Lena Oevermann

Blood (2023) 142 (Supplement 1): 7036.

https://doi.org/10.1182/blood-2023-180543

Published: 2023

Journal Articles

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Mariane de Montalembert, Frédéric Galactéros, Lena Oevermann, Giovanna Cannas, Laure Joseph, Gylna Loko, Narcisse Elenga, Malika Benkerrou, Maryse Etienne-Julan, Marie-Pierre Castex, Regine Grosse, Valentine Brousse

Blood (2022) 140 (Supplement 1): 449–450.

https://doi.org/10.1182/blood-2022-165946

Published: 2022

Journal Articles

Benefits of a Disease Management Program for SCD in Germany 2011 - 2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome

Joachim B. Kunz, Andreas Schlotmann, Andrea Daubenbüchel, Stephan Lobitz, Andrea Jarisch, Regine Grosse, Holger Cario, Lena Oevermann, Dani Hakimeh, Laura Tagliaferri, Andreas E. Kulozik

Blood (2021) 138 (Supplement 1): 973.

https://doi.org/10.1182/blood-2021-148550

Published: 2021

Journal Articles

Implementation of Escort-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study : Interests and Methodology

Mariane de Montalembert, Ersi Voskaridou, Lena Oevermann, Giovanna Cannas, Anoosha Habibi, Gylna Loko, Laure Joseph, Raffaella Colombatti, Pablo Bartolucci, Valentine Brousse, Frédéric Galactéros

Blood (2021) 138 (Supplement 1): 3098.

https://doi.org/10.1182/blood-2021-152525

Published: 2021

Journal Articles

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Lena Oevermann, MD, Mariane De Montalembert, MD PhD, Malika Benkerrou, MD, Valentine Brousse, MD, Corinne Pondarré, MD PhD, Marie Petras, MD, Marie Belloy, MD, Narcisse Elenga, MD PhD

Blood (2018) 132 (Supplement 1): 1079.

https://doi.org/10.1182/blood-2018-99-114441

Published: 2018

Journal Articles

Sustainability of Hematological and Clinical Benefits to HU Administration in the Prevention of Sickle-Cell Vaso-Occlusive Crises in Routine Practice

Ersi Voskaridou, MD, Lena Oevermann, MD, Corinne Armari-Alla, MD, Uwe Kordes, MD MRCP, Frédéric Galactéros, MDPhD, Malika Benkerrou, MD, Isabelle Thuret, MD, Dominique Steschenko, MD

Blood (2018) 132 (Supplement 1): 855.

https://doi.org/10.1182/blood-2018-99-116040

Published: 2018

Journal Articles

Management of Infections in SCD Patients Treated with HU in the Framework of Escort HU

Frédéric Galactéros, MDPhD, Malika Benkerrou, MD, Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD, Corinne Pondarré, MD PhD, Jean Benoît Arlet, MD, Uwe Kordes, MD MRCP, Regine Grosse, MD, Valentine Brousse, MD, Lena Oevermann, MD, Stephan Lobitz, MD

Blood (2017) 130 (Supplement 1): 3543.

https://doi.org/10.1182/blood.V130.Suppl_1.3543.3543

Published: 2017

Journal Articles

No association between the presence of killer-cell immunoglobulin-like receptor genes and susceptibility to childhood ALL

Lena Oevermann, Matthias Firnkorn, Sebastian Michaelis, Simon Müller, Elke Schaeffeler, Martin Schrappe, Gunnar Cario, Martin Stanulla, Matthias Schwab, Rupert Handgretinger, Markus Mezger

Blood (2015) 125 (21): 3355–3357.

https://doi.org/10.1182/blood-2015-02-628339

Published: 2015

Journal Articles

Both mature KIR + and immature KIR − NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdc scid IL2rg tmWjl /Sz mice

Ayline Kübler, Jeanette Woiterski, Kai-Erik Witte, Hans-Jörg Bühring, Udo F. Hartwig, Martin Ebinger, Lena Oevermann, Markus Mezger, Wolfgang Herr, Peter Lang, Rupert Handgretinger, Christian Münz, Maya C. André

Blood (2014) 124 (26): 3914–3923.

https://doi.org/10.1182/blood-2014-05-572743

Published: 2014

Includes: Supplemental data

Journal Articles

KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL

Lena Oevermann, Sebastian U. Michaelis, Markus Mezger, Peter Lang, Jacek Toporski, Alice Bertaina, Marco Zecca, Lorenzo Moretta, Franco Locatelli, Rupert Handgretinger

Blood (2014) 124 (17): 2744–2747.

https://doi.org/10.1182/blood-2014-03-565069

Published: 2014

Journal Articles

Genetic Association Analysis Between KIR2DS4 and Its Variant KIR1D With Pediatric Acute Lymphoblastic Leukemia

Markus Mezger, PhD, Sebastian Michaelis, cand.med., Renate Koch, MTA, Matthias Firnkorn, MD, Lena Oevermann, MD, Rupert Handgretinger, Prof.

Blood (2013) 122 (21): 3363.

https://doi.org/10.1182/blood.V122.21.3363.3363

Published: 2013

Journal Articles

KIR Haplotype B Donors but Not KIR-Ligand Mismatch Result in a Reduced Risk of Relapse After Haploidentical Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning and a CD3/CD19 Depleted Graft.

Sebastian Michaelis, cand.med., Markus Mezger, PhD, Martin Bornhauser, MD, Rudolf Trenschel, Gernot Stuhler, MD, Matthias Stelljes, MD, Lutz P Mueller, MD, Herrad Baurmann, MD, Birgit Federmann, MD, Lena Oevermann, MD, Lothar Kanz, MD, Rupert Handgretinger, MD, Wolfgang A. Bethge, MD

Blood (2012) 120 (21): 3101.

https://doi.org/10.1182/blood.V120.21.3101.3101

Published: 2012

Journal Articles

Reduced Risk of Relapse In Pediatric ALL After Haploidentical Transplantation of T-Cell Depleted Grafts From KIR Haplotype B Donors,

Lena Oevermann, MD, Sebastian Michaelis, cand.med., Markus Mezger, PhD, Matthias Pfeiffer, MD, Peter Lang, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD

Blood (2011) 118 (21): 4133.

https://doi.org/10.1182/blood.V118.21.4133.4133

Published: 2011

NARROW

Artificial Intelligence (AI) Based, Machine Learning (ML) Predicting the Individual Absolute Risk of Acute Graft Versus Host Disease (aGvHD) in a Retrospective International Cohort

Establishing Standard of Care in Predicting Serious Complications for Patients Planned to Undergo Allogenic Hematopeotic Stem Cell Transplantation

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Benefits of a Disease Management Program for SCD in Germany 2011 - 2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome

Implementation of Escort-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study : Interests and Methodology

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Sustainability of Hematological and Clinical Benefits to HU Administration in the Prevention of Sickle-Cell Vaso-Occlusive Crises in Routine Practice

Management of Infections in SCD Patients Treated with HU in the Framework of Escort HU

No association between the presence of killer-cell immunoglobulin-like receptor genes and susceptibility to childhood ALL

Both mature KIR + and immature KIR − NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdc scid IL2rg tmWjl /Sz mice

KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL

Genetic Association Analysis Between KIR2DS4 and Its Variant KIR1D With Pediatric Acute Lymphoblastic Leukemia

KIR Haplotype B Donors but Not KIR-Ligand Mismatch Result in a Reduced Risk of Relapse After Haploidentical Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning and a CD3/CD19 Depleted Graft.

Reduced Risk of Relapse In Pediatric ALL After Haploidentical Transplantation of T-Cell Depleted Grafts From KIR Haplotype B Donors,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only